ProPhase Labs, Inc. (PRPH)

ProPhase Labs Market Cap

ProPhase Labs has a market cap or net worth of $72.50 million as of July 2, 2024. Its market cap has decreased by -42.51% in one year.

• Market Cap: 72.50M
• Enterprise Value: 94.04M
• 1-Year Change: -42.51%
• Ranking: #4247
• Category: Micro-Cap
• Stock Price: $3.80

Market Cap Chart

Since December 1, 1998, ProPhase Labs's market cap has decreased from $92.00M to $72.50M, a decrease of -21.20%. That is a compound annual growth rate of -0.93%.

Market Cap History

Date	Market Cap	% Change
Jul 1, 2024	77.50M	-5.02%
Dec 29, 2023	81.60M	-47.96%
Dec 30, 2022	156.80M	41.01%
Dec 31, 2021	111.20M	4.41%
Dec 31, 2020	106.50M	367.11%
Dec 31, 2019	22.80M	-37.36%
Dec 31, 2018	36.40M	34.81%
Dec 29, 2017	27.00M	-21.05%
Dec 30, 2016	34.20M	33.59%
Dec 31, 2015	25.60M	13.27%
Dec 31, 2014	22.60M	-11.72%
Dec 31, 2013	25.60M	26.73%
Dec 31, 2012	20.20M	19.53%
Dec 30, 2011	16.90M	-3.98%
Dec 31, 2010	17.60M	-30.98%
Dec 31, 2009	25.50M	-50.58%
Dec 31, 2008	51.60M	-15.69%
Dec 31, 2007	61.20M	-15.24%
Dec 29, 2006	72.20M	-55.24%
Dec 30, 2005	161.30M	64.42%
Dec 31, 2004	98.10M	-19.85%
Dec 31, 2003	122.40M	94.29%
Dec 31, 2002	63.00M	156.10%
Dec 31, 2001	24.60M	179.55%
Dec 29, 2000	8.80M	-46.67%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Ikena Oncology	79.63M
Connect Biopharma Holdings	79.35M
DBV Technologies	78.77M
Allakos	77.90M
Chimerix	77.89M
FibroGen	76.61M
Oncolytics Biotech	75.49M
MAIA Biotechnology	75.12M